These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3015160)

  • 1. [Immunoblastic lymphoma after bone marrow graft. Apropos of a case treated by OKT3 monoclonal antibodies for an acute graft versus host reaction].
    Faure P; d'Agay MF; Tricot G; Gluckman E; Brocheriou C
    Ann Pathol; 1986; 6(2):137-43. PubMed ID: 3015160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of steroid-resistant graft-versus-host disease after allogeneic bone marrow transplantation with anti-CD3/TCR monoclonal antibodies.
    Hebart H; Ehninger G; Schmidt H; Berner B; Reuss-Borst M; Waller HD; Müller CA; Einsele H
    Bone Marrow Transplant; 1995 Jun; 15(6):891-4. PubMed ID: 7581087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
    Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of donor bone marrow with OKT3 (PAN-T monoclonal antibody) for prophylaxis of graft-vs.-host disease (GvHD) in histocompatible allogeneic bone marrow transplantation (BMT): a pilot study.
    Filipovich AH; McGlave P; Ramsay NK; Goldstein G; Kersey JH
    J Clin Immunol; 1982 Jul; 2(3 Suppl):154S-157S. PubMed ID: 6752174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of a patient with graft versus host reaction following allogenic bone marrow transplantation with the monoclonal antibody OKT3 (Orthoclone OKT3)].
    Jung G; Holler E; Kolb HJ; Wilmanns W
    Internist (Berl); 1989 Jun; 30(6):386-8. PubMed ID: 2503460
    [No Abstract]   [Full Text] [Related]  

  • 6. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K; Itoh M; Shimada H
    Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of monoclonal antibodies to bone marrow transplantation].
    Morishima Y
    Gan To Kagaku Ryoho; 1988 May; 15(5):1693-701. PubMed ID: 3285796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
    Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of steroid-resistant acute graft-versus-host disease with an anti-IL-2-receptor monoclonal antibody (BT 563) in children who received T cell-depleted, partially matched, related bone marrow transplants.
    Herbelin C; Stephan JL; Donadieu J; Le Deist F; Racadot E; Wijdenes J; Fischer A
    Bone Marrow Transplant; 1994 May; 13(5):563-9. PubMed ID: 8054909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC; McGuire TR
    Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of steroid-resistant acute graft-vs-host disease after allogeneic marrow transplantation with anti-interleukin-2 receptor antibody (BT563).
    Hertenstein B; Stefanic M; Sandherr M; Bunjes D; Mertens T; Arnold R
    Transplant Proc; 1994 Dec; 26(6):3114-6. PubMed ID: 7998086
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bone marrow graft: graft versus host reaction and rejection].
    Fischer A; Griscelli C
    Nephrologie; 1986; 7(3 Suppl):1-4. PubMed ID: 3534616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation for acute leukaemia and severe marrow aplasia: an analysis of five patients.
    Beard ME; Heaton DC; Hamer JW; Watson J; Fox HW; Crosier PS; Abbott GD
    N Z Med J; 1981 Oct; 94(693):249-52. PubMed ID: 7033845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of acute grade IV skin and eye graft-versus-host disease by anti-interleukin-2 receptor monoclonal antibody in genoidentical bone marrow transplantation setting.
    Ozşahin H; Tuchschmid P; Lauener R; Waldvogel K; Nadal D; Seger RA
    Turk J Pediatr; 1998; 40(2):231-5. PubMed ID: 9677728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-versus-host disease in allogeneic bone marrow transplantation: the role of monoclonal antibodies in prevention and treatment.
    Hiscott A; McLellan DS
    Br J Biomed Sci; 2000; 57(2):163-9. PubMed ID: 10912294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late onset Epstein-Barr virus-associated lymphoproliferative disease after allogeneic bone marrow transplant presenting as breast masses.
    Abhyankar SH; Chiang KY; McGuirk JP; Pati AR; Godder KT; Welsh JA; Waldron RL; McElveen JL; Henslee-Downey PJ
    Bone Marrow Transplant; 1998 Feb; 21(3):295-7. PubMed ID: 9489654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transplantation of allogeneic bone marrow treated in vitro with Campath-1 monoclonal antibody].
    Chapuis B; Helg C; Maurice P; Wyss M; Pipard G; Irlé C; Jeannet M
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1521-2. PubMed ID: 3909387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OKT3 incubation of donor marrow for prophylaxis of acute graft-vs.-host disease (GvHD) in allogeneic bone marrow transplantation.
    Prentice HG
    J Clin Immunol; 1982 Jul; 2(3 Suppl):148S-153S. PubMed ID: 6290527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
    Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.